CA2277544A1 - Identification d'inhibiteurs de la proteine tyrosine-kinase 2 - Google Patents
Identification d'inhibiteurs de la proteine tyrosine-kinase 2 Download PDFInfo
- Publication number
- CA2277544A1 CA2277544A1 CA002277544A CA2277544A CA2277544A1 CA 2277544 A1 CA2277544 A1 CA 2277544A1 CA 002277544 A CA002277544 A CA 002277544A CA 2277544 A CA2277544 A CA 2277544A CA 2277544 A1 CA2277544 A1 CA 2277544A1
- Authority
- CA
- Canada
- Prior art keywords
- pyk2
- compound
- ability
- activity
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
La présente invention concerne des dosages de composés qui se lient à la protéine tyrosine-kinase 2 ou qui modulent son activité. Ces ligands sont utilisés pour le traitement de l'ostéoporose et/ou de l'inflammation.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3756097P | 1997-02-11 | 1997-02-11 | |
US60/037,560 | 1997-02-11 | ||
PCT/US1998/002797 WO1998035056A1 (fr) | 1997-02-11 | 1998-02-09 | Identification d'inhibiteurs de la proteine tyrosine-kinase 2 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2277544A1 true CA2277544A1 (fr) | 1998-08-13 |
Family
ID=21895000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002277544A Abandoned CA2277544A1 (fr) | 1997-02-11 | 1998-02-09 | Identification d'inhibiteurs de la proteine tyrosine-kinase 2 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0968304A1 (fr) |
JP (1) | JP2001512309A (fr) |
AU (1) | AU6163398A (fr) |
CA (1) | CA2277544A1 (fr) |
WO (1) | WO1998035056A1 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6165598A (en) | 1997-02-18 | 1998-09-08 | Lxr Biotechnology Inc. | Bak promotor expression system |
EP1630559A3 (fr) * | 1998-12-30 | 2006-06-07 | Sugen, Inc. | PYK2 (RAFTK) et inflammation |
AU2209899A (en) * | 1998-12-30 | 2000-07-24 | Sugen, Inc. | Pyk2 (raftk) and inflammation |
US6861442B1 (en) | 1998-12-30 | 2005-03-01 | Sugen, Inc. | PYK2 and inflammation |
AU5951201A (en) * | 2000-05-04 | 2001-11-12 | Univ Yale | High density protein arrays for screening of protein activity |
AU2002236692A1 (en) * | 2000-10-23 | 2002-05-21 | Bristol-Myers Squibb Company | Modulators of bruton's tyrosine kinase and bruton's tyrosine kinase, their identification and use |
JP2004537542A (ja) | 2001-06-29 | 2004-12-16 | アブ サイエンス | 炎症性腸疾患(ibd)を治療するための、チロシンキナーゼ阻害剤の使用 |
EP1401413B1 (fr) | 2001-06-29 | 2006-11-22 | AB Science | Utilisation d'inhibiteurs de tyrosine kinase dans le traitement de maladies allergiques |
JP2005500041A (ja) | 2001-06-29 | 2005-01-06 | アブ サイエンス | 強力で選択的かつ非毒性のc−kit阻害剤 |
DE60212627T2 (de) | 2001-06-29 | 2007-06-14 | Ab Science | Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung von entzündlichen Krankheiten |
JP2004530722A (ja) * | 2001-06-29 | 2004-10-07 | アブ サイエンス | 骨喪失を治療するためのチロシンキナーゼ阻害剤の使用法 |
US20050170431A1 (en) * | 2003-02-28 | 2005-08-04 | Plexxikon, Inc. | PYK2 crystal structure and uses |
CA2571482A1 (fr) * | 2004-06-21 | 2005-12-29 | Pharmacia & Upjohn Company Llc | Inhibiteurs de pyk2 pour la stimulation de la fonction de l'osteoblaste |
-
1998
- 1998-02-09 CA CA002277544A patent/CA2277544A1/fr not_active Abandoned
- 1998-02-09 EP EP98906400A patent/EP0968304A1/fr not_active Withdrawn
- 1998-02-09 AU AU61633/98A patent/AU6163398A/en not_active Abandoned
- 1998-02-09 JP JP53507198A patent/JP2001512309A/ja active Pending
- 1998-02-09 WO PCT/US1998/002797 patent/WO1998035056A1/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU6163398A (en) | 1998-08-26 |
EP0968304A1 (fr) | 2000-01-05 |
WO1998035056A1 (fr) | 1998-08-13 |
JP2001512309A (ja) | 2001-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU697142B2 (en) | Protein tyrosine kinases named Rse | |
Pasqualini et al. | Contrasting roles for integrin beta 1 and beta 5 cytoplasmic domains in subcellular localization, cell proliferation, and cell migration. | |
US7446176B2 (en) | 12 human secreted proteins | |
US20040018980A1 (en) | Novel FIZZ proteins | |
CA2277544A1 (fr) | Identification d'inhibiteurs de la proteine tyrosine-kinase 2 | |
CA2331239A1 (fr) | Structure, fabrication et utilisation de l'hereguline | |
IE920317A1 (en) | Domains of extracellular region of human platelet-derived¹growth factor receptor polypeptides | |
CA2111573C (fr) | Materiel de cadherine et methodes | |
WO2002032288A2 (fr) | Chimiotaxie modulee du gene cd38 | |
TWI356097B (en) | Ccn1 compositions and methods | |
US20030044899A1 (en) | Isolated laminin 10 | |
US6210913B1 (en) | Modulation of integrin-mediated signal transduction | |
David et al. | Integrins interact with focal adhesions through multiple distinct pathways | |
NZ524342A (en) | Receptor in the EDb fibronectin domain | |
AU8501198A (en) | Methods and compositions for regulating nuclear trafficking of proteins | |
KR20040031031A (ko) | 면역 관련 질환 치료용 조성물 및 치료 방법 | |
JP3755649B2 (ja) | 細胞接着、伸張、および剥離活性を示すペプチドおよびその誘導体 | |
EP2843048B1 (fr) | NOUVEAU LIGAND DE L'INTÉGRINE alpha9beta1 ET SES UTILISATIONS | |
WO2000059940A2 (fr) | Gene et proteine lies au facteur de croissance d'origine plaquettaire | |
JP4349662B2 (ja) | 可溶性組換えαvβ3付着受容体 | |
Madden et al. | A peptide derived from neutrophil inhibitory factor (NIF) blocks neutrophil adherence to endothelial cells | |
KR100481796B1 (ko) | 섬유아세포의 αvβ5 인테그린과 특이적으로 결합하는βig-h3 단백질 유래 펩타이드 | |
CA2277028A1 (fr) | Proteine tyrosine-kinase 2 (pyk2), acides nucleiques et methode de detection | |
US20170145391A1 (en) | TRUNCATED VARIANT OF THE MAMMALIAN TARGET FOR RAPAMYCIN (mTOR) PROTEIN | |
Shen | The Role of Galpha13 in Integrin Signaling and Function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |